Skip to main content
. 2024 Jul 6;14:15618. doi: 10.1038/s41598-024-66405-2

Figure 2.

Figure 2

Two-way sensitivity analysis for cost difference per patient by the detected diabetic maculopathy and the OCT cost increase for sequential compared to combined screening.